Create Account
U
20/20 GeneSystems Inc.
TWTG
OTC PK
$3.50 $0.000.00% Volume125 03/17/2022 2:02PM Eastern Quotes delayed
Recommendation
--
Prev Close
$3.50
Avg Vol (90D)
9
Market Cap
$16.55M
Dividend & Yield
--
52-Week Range
$3.20 - $7.00
P/E (TTM)
--
EPS (TTM)
--
My Lists My Alerts
Rating
Reward
U
Unrated
Risk
U
Unrated
Rating Factors
Growth Index
Unrated
Efficiency Index
Unrated
Solvency Index
Unrated
Total Return Index
Unrated
Volatility Index
Unrated
Dividend Index
Unrated
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
--
Total Debt (Q)
--
Total Liabilities (Q)
--
Book Value Per Share (Q)
--
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Period Date
Next Filing
(est)
Price History
Loading...
Beta
--
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
2.94%
90-Day Total Return
7.69%
Year to Date Total Return
9.38%
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Dec 27, 2021 - $3.20
52-week High
Sep 20, 2021 - $7.00
Valuation
Market Cap
$16.55M - Nano Cap
Enterprise Value
--
Price/Sales (TTM)
--
Price/Book (Q)
--
Dividends and Shares
Shares Outstanding
--
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
2020gene.com
Phone Number
240 453 6339
Address
9430 Key West Avenue
Rockville, MD 20850
Country
United States
Year Founded
2000
Business Description
Sector
Health Care
Industry
Health Care Equipment and Services
20/20 GeneSystems Inc., a clinical laboratory testing company, develops and commercializes artificial intelligence powered cancer screenings tests for the earlier detection of multiple cancers... more
Weiss Ratings